首页|期刊导航|医药导报|Nur77通过抑制上皮-间质转化抗肝纤维化的机制

Nur77通过抑制上皮-间质转化抗肝纤维化的机制OA

Mechanism of Nur77 Against Liver Fibrosis via Inhibition of Epithelial-Mesenchymal Transition

中文摘要英文摘要

目的 探讨孤核受体 Nur77 靶向上皮-间质转化抗肝纤维化的机制.方法 将 C57/BL6 小鼠 40 只随机分为阴性对照组(NC 组)、肝纤维化模型组(NM 组)、Nur77 过表达对照组(OEC 组)和 Nur77 过表达模型组(OEM 组),每组10 只.小鼠腹腔注射四氯化碳橄榄油溶液建立肝纤维化模型;OEC 组尾静脉注射Nur77 过表达病毒200 μL;NC 组和NM 组均尾静脉注射阴性对照病毒 200 μL.干预后检测肝功能和病理改变,蛋白印迹法和免疫荧光检测 α-平滑肌肌动蛋白(α-SMA)、E-钙粘蛋白(E-cadherin)、Nur77、磷脂酰肌醇 3-激酶(PI3K)等蛋白的表达水平.细胞实验采用人肝星状细胞 LX-2,给予血小板衍生生长因子-BB(PDGF-BB)活化造模.结果 ①造模 8 周后,NM 组体重较 NC 组、OEM 组均显著降低(均 P<0.05).②OEM 组与 NM 组比较,丙氨酸氨基转移酶、天冬氨酸氨基转移酶水平均明显降低(均P<0.05).苏木精-伊红染色显示,与 NM 组比较,OEM 组病理损伤程度减轻,胶原纤维分布减少.③蛋白印迹和免疫荧光检测显示,NM 组 α-SMA 蛋白与 NC 组相比表达明显增高(P<0.05),OEM 组的 α-SMA 表达相对 NM 组明显降低(P<0.05).④免疫组化染色显示,NM 组 E-cadherin 阳性细胞数及表达量较 NC 组明显减少;OEM 组黄色表达区域较 NM 组明显增多(P<0.05).⑤NM 组相比 NC 组 Nur77 蛋白表达明显减少;OEM 组 Nur77 蛋白表达相对 NM 组明显增多.⑥转录组测序(RNA-seq)分析发现磷酸化磷脂酰肌醇3-激酶/蛋白激酶B(p-PI3K/Akt)信号通路显著富集;蛋白印迹显示,与NC 组比较,NM 组磷酸化蛋白激酶 B(p-Akt)/Akt 和 p-PI3K/PI3K 明显升高(P<0.05);相比 NM 组,OEM 组的 p-PI3K/PI3K 和 p-Akt/Akt 明显下降(P<0.05).结论 Nur77 对小鼠肝纤维化模型上皮-间质转化具有抑制作用,其机制与调控PI3K/Akt 信号轴有关,可为防治肝纤维化的精准治疗提供新的思路和干预靶点.

Objective To explore the mechanism of the orphan nuclear receptor Nur77 targeting epithelial-mesenchymal transition to combat liver fibrosis.Methods Forty C57/BL6 mice were randomly divided into four groups:negative control(NC),hepatic fibrosis model(NM),Nur77 overexpression control(OEC),and Nur77 overexpression model(OEM),with 10 mice per group.Hepatic fibrosis was induced in mice via intraperitoneal injection of carbon tetrachloride in olive oil.The OEC group received an intravenous injection of 200 μL of Nur77 overexpression virus,while the NC and NM groups received an intravenous injection of 200 μL of a negative control virus.Following the intervention,hepatic function and pathological alterations were assessed.Protein levels of α-SMA,E-cadherin,Nur77,and PI3K were detected using Western blotting and immunofluorescence.For cellular experiments,human hepatic stellate cells(LX-2)were activated and cultured with PDGF-BB.Results ① After 8 weeks of model induction,the body weight of the NM group was significantly lower than that of the NC and OEM groups(both P<0.05).② Compared to the NM group,the levels of ALT and AST in the OEM group were significantly reduced(both P<0.05).HE staining revealed that,compared with the NM group,the OEM group exhibited reduced severity of pathological injury and decreased collagen fiber distribution.③ Western blotting and immunofluorescence assays demonstrated that α-SMA protein expression was significantly elevated in the NM group compared to the NC group(P<0.05),and α-SMA expression was markedly reduced in the OEM group relative to the NM group(P<0.05).④ Immunohistochemical staining indicated that the number and expression level of E-cadherin positive cells were significantly decreased in the NM group compared to the NC group;the yellow positive staining area was notably increased in the OEM group compared to the NM group(P<0.05).⑤ Nur77 protein expression was significantly reduced in the NM group compared to the NC group;Nur77 protein expression was markedly increased in the OEM group relative to the NM group.⑥ RNA-seq analysis revealed significant enrichment of the PI3K/Akt signaling pathway;Western blotting analysis showed that p-Akt/Akt and p-PI3K/PI3K were significantly elevated in the NM group compared to the NC group(P<0.05);in contrast to the NM group,the OEM group exhibited a significant decrease in p-PI3K/PI3K and p-Akt/Akt(P<0.05).Conclusions Nur77 inhibits epithelial-mesenchymal transition in a mouse model of liver fibrosis.Its mechanism involves the regulation of the PI3K/Akt signaling axis,offering novel strategies and intervention targets for the precise treatment of liver fibrosis.

刘媛;冷银花;杨馨月;吕腾飞;吉卿钰;孔博研;欧阳萁;毕研蒙

济宁医学院中西医结合学院,济宁 272067济宁医学院中西医结合学院,济宁 272067济宁医学院中西医结合学院,济宁 272067济宁医学院中西医结合学院,济宁 272067济宁医学院中西医结合学院,济宁 272067济宁医学院中西医结合学院,济宁 272067济宁医学院中西医结合学院,济宁 272067济宁医学院中西医结合学院,济宁 272067

医药卫生

Nur77上皮-间质转化肝纤维化肝星状细胞

Nur77Epithelial-mesenchymal transitionLiver fibrosisHepatic stellate cells

《医药导报》 2026 (9)

1498-1506,9

国家自然科学基金资助项目(82305215)山东省自然科学基金资助项目(ZR2023MH312)山东省医药卫生科学技术发展项目(202103030820、202203030635)大学生创新创业训练计划项目(cx2025104).

10.3870/j.issn.1004-0781.2026.09.003

评论